Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas

Table 1

Distribution of ameloblastomas according to clinical features.

Clinical features	UAM-L/I ()	UAM-M ()	SMA ()
Gender
Male	21 (55.3%)	16 (69.6%)	19 (50%)
Female	17 (44.7%)	7 (30.4%)	19 (50%)
Mean age, years
<30.4	26 (68.4%)	14 (60.9%)	17 (44.7%)
≥30.4	12 (31.6%)	9 (39.1%)	21 (55.3%)
Site of localization
Maxilla
Anterior	2 (5.3%)	0	0
Posterior	1 (2.6%)	0	0
Mandible
Anterior	1 (2.6%)	1 (4.3%)	1 (2.6%)
Posterior	34 (89.4%)	22 (95.7%)	37 (97.4%)
Radiographic
Unilocular	26 (68.4%)	16 (69.6%)	12 (31.6%)
Multilocular	8 (21%)	3 (13%)	18 (47.4%)
Unknown	4 (10.5%)	4 (17.4%)	8 (21%)
Size (cm)
<5.3	23 (60.5%)	17 (74%)	23 (60.5%)
≥5.3	15 (39.4%)	6 (26%)	15 (39.5%)
Recurrence
Yes	2 (5.3%)	2 (8.7%)	3 (7.9%)
No	36 (94.7%)	21 (91.3%)	35 (92.1%)

Body and/or ramus.